Medios AG Logo

Medios AG

Wholesale and manufacturing of specialty pharmaceuticals for complex and rare diseases.

ILM1 | F

Overview

Corporate Details

ISIN(s):
DE000A1MMCC8 (+1 more)
LEI:
391200Z7Z09IHDBT2L23
Country:
Germany
Address:
Heidestraße 9, 10557 Berlin

Description

Medios AG is a specialty pharmaceutical company focused on providing solutions for complex and rare diseases. The company's core business encompasses two main segments: the wholesale distribution of specialty pharma drugs and the manufacturing of patient-specific therapies. The manufacturing division compounds personalized medications, such as sterile infusions, for individual patients. As a comprehensive partner, Medios covers critical aspects of the supply chain for specialized pharmacies, medical practitioners, and pharmaceutical companies. The company is also dedicated to advancing individualized medicine by pioneering biotechnological precision medicine and advanced therapies to provide patients with innovative treatments.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-01-19 16:00 English 14.6 KB
2022-01-18 15:56
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
English 4.2 KB
2022-01-11 08:57
Medios AG: Successful completion of the acquisition of the NewCo Pharma Group …
English 9.5 KB
2021-12-16 10:55
Medios AG adopts sustainability strategy and plans climate neutrality by 2023
English 10.5 KB
2021-12-14 14:17
Medios AG: Planned takeover of NewCo Pharma Group approved by Cartel Office
English 8.4 KB
2021-12-13 13:12 English 4.4 KB
2021-12-13 13:08 English 4.8 KB
2021-12-09 12:10
DGAP-DD: Medios AG english
English 7.6 KB
2021-12-09 12:05
DGAP-DD: Medios AG english
English 7.7 KB
2021-12-09 12:00
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
English 4.2 KB
2021-12-08 12:00 English 17.0 KB
2021-12-07 14:00 English 13.7 KB
2021-12-06 15:00
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
English 4.2 KB
2021-12-03 08:01
Medios AG successfully completes capital increase with gross proceeds of approx…
English 13.0 KB
2021-12-02 17:40
Medios AG resolves on capital increase against cash contributions of up to 10% …
English 14.9 KB

Automate Your Workflow. Get a real-time feed of all Medios AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medios AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Medios AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-08-19 van Rietschoten, Constantijn Board Buy None 162,805.82 EUR
2023-06-28 Prußeit, Christoph Board Buy None 39,100.00 EUR
2021-12-09 Miehler, Mi-Young Board Other None 3,550,000.00 EUR
2021-12-09 Prußeit, Christoph Board Other None 1,775,000.00 EUR
2021-12-09 Miehler, Mi-Young Board Other None 700,000.00 EUR
2021-12-09 Prußeit, Christoph Board Other None 350,000.00 EUR

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.